The third annual Paul M. Fernhoff Memorial Lecture was held Thursday, September 17, 2015. Dr. Philip Farrell’s keynote address is available here entitled “A Miraculous New Era for Cystic Fibrosis: … More →
Routine Second Testing in Newborn Screening for Hypothyroidism and Congenital Adrenal Hyperplasia: Is One Screening Test Sufficient?
Dr. Shapira presents on Newborn Screening for Hypothyroidism and Congenital Adrenal Hyperplasia.
Dr. Zuckerman presents at the 2010 SERGG Annual Meeting.
Dr. Therrell presents at the 2010 SERGG Annual Meeting.
Stephanie DeArmey presents “Pompe Disease: Newborn Screening Initiative in the US”. Note that due to PHI, portions of the video slides are blacked out. The audio will continue to play.
Dr. Kobrynski presents at the 2011 SERC-SERGG Annual Conference.
Dr. Wood presents on VLCAD and GA1 newborn screening in South Carolina for the Lunch and Learn series.
Dr. Amy Yang presents “Newborn Screening for Pompe Disease: Lessons Learned from New York”
On March 1, 2010, Dr. Michael J. Bennett of The Children’s Hospital of Philadelphia presented “New developments with fatty acid oxidation defects” at Emory University’s Grand Rounds in Atlanta, GA.
Update on Activities of the Secretary’s (Discretionary) Advisory Committee on Heritable Disorders in Newborns and Children
Dr. Bochinni presents on SACHDNC activities.
Dr. Hinton presents on newborn screening for critical congenital heart disease.
Dr. Kemper presents on the SACHDNC approach to considering conditions for newborn screening (NBS).
Meg Comeau presents on the ACA.
Dr. Sontag presents on NewSTEPs.
Dr. Kemper presents Newborn Screening for MPS I: Evidence and Rationale.
Dr. Pasquali presents, “Newborn Screening for GAMT Deficiency: The Utah Experience”
Succinylacetone as Primary Marker to Detect Tyrosinemia Type I in Newborns and Its Measurement by Newborn Screening Programs
Dr. De Jesus presents “Succinylacetone as Primary Marker to Detect Tyrosinemia Type I in Newborns and Its Measurement by Newborn Screening Programs”